Pharmaceutical Press of the Royal Pharmaceutical Society on Thursday (23) announced the release of essential drug information to support those working in critical care through the Covid-19 crisis.
The information is available to the NHS in England, Northern Ireland, Scotland and Wales, and to Medicines Complete users at no charge.
Critical Illness is a new resource planned for publication next year, providing healthcare professionals working in intensive care units with specific guidance to help them make confident and effective decisions in this high-risk environment. Due to these exceptional circumstances, all available content is being released now.
The advance release of Critical Illness, compiled by consultants and specialist pharmacists working in critical care, comprises six monographs and prescribing guidance considered core for critical care units that follow dosing outside of standard regimens and are specifically useful for adult Covid-19 patients.